10
IRUS Total
Downloads

Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study

File Description SizeFormat 
s13756-020-0695-z.pdfPublished version1.09 MBAdobe PDFView/Open
Title: Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study
Authors: Birgand, G
Mutters, NT
Ahmad, R
Tacconelli, E
Lucet, J-C
Holmes, A
Item Type: Journal Article
Abstract: Background Using case-vignettes, we assessed the perception of European infection control (IC) specialists regarding the individual and collective risk associated with antimicrobial resistance (AMR) among inpatients. Methods In this study, sixteen case-vignettes were developed to simulate hospitalised patient scenarios in the field of AMR and IC. A total of 245 IC specialists working in different hospitals from 15 European countries were contacted, among which 149 agreed to participate in the study. Using an online database, each participant scored five randomly-assigned case-vignettes, regarding the perceived risk associated with six different multidrug resistant organisms (MDRO). The intra-class correlation coefficient (ICC), varying from 0 (poor) to 1 (perfect), was used to assess the agreement for the risk on a 7-point Likert scale. High risk and low/neutral risk scorers were compared regarding their national, organisational and individual characteristics. Results Between January and May 2017, 149 participants scored 655 case-vignettes. The perceptions of the individual (clinical outcome) and collective (spread) risks were consistently lower than other MDRO for extended spectrum beta-lactamase producing Enterobacteriaceae cases and higher for carbapenemase producing Enterobacteriaceae (CPE) cases. Regarding CPE cases, answers were influenced more by the resistance pattern (93%) than for other MDRO. The risk associated with vancomycin resistant Enterococci cases was considered higher for the collective impact than for the individual outcome (63% vs 40%). The intra-country agreement regarding the individual risk was globally poor varying from 0.00 (ICC: 0–0.25) to 0.51 (0.18–0.85). The overall agreement across countries was poor at 0.20 (0.07–0.33). IC specialists working in hospitals preserved from MDROs perceived a higher individual (local, p = 0.01; national, p < 0.01) and collective risk (local and national p < 0.01) than those frequently exposed to bacteraemia. Conversely, IC specialists working in hospitals with a high MDRO clinical burden had a decreased risk perception. Conclusions The perception of the risk associated with AMR varied greatly across IC specialists and countries, relying on contextual factors including the epidemiology. IC specialists working in high prevalence areas may underestimate both the individual and collective risks, and might further negatively promote the MDRO spread. These finding highlight the need to shape local and national control strategies according to risk perceptions and contextual factors.
Issue Date: 14-Feb-2020
Date of Acceptance: 6-Feb-2020
URI: http://hdl.handle.net/10044/1/77673
DOI: 10.1186/s13756-020-0695-z
ISSN: 2047-2994
Publisher: BioMed Central
Journal / Book Title: Antimicrobial Resistance and Infection Control
Volume: 9
Copyright Statement: © The Author(s). 2020. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sponsor/Funder: ESRC
National Institute for Health Research
National Institute for Health Research
Funder's Grant Number: HPRU-2012-10047
HPRU-2012-10047
Keywords: Science & Technology
Life Sciences & Biomedicine
Public, Environmental & Occupational Health
Infectious Diseases
Microbiology
Pharmacology & Pharmacy
Europe
Infection prevention and control
Antimicrobial resistance
Risk perception
Carbapenemase-producing Enterobacteriaceae
Meticillin-resistant Staphylococcus aureus
Carbapenemase-producing Pseudomonas aeruginosa
Carbapenemase-producing Acinetobacter baumannii
Vancomycin-resistant Enterococci
GUIDELINES
PHYSICIANS
MORTALITY
Antimicrobial resistance
Carbapenemase-producing Acinetobacter baumannii
Carbapenemase-producing Enterobacteriaceae
Carbapenemase-producing Pseudomonas aeruginosa
Europe
Infection prevention and control
Meticillin-resistant Staphylococcus aureus
Risk perception
Vancomycin-resistant Enterococci
Percept-R Study Group
0605 Microbiology
1103 Clinical Sciences
1108 Medical Microbiology
Publication Status: Published
Article Number: ARTN 33
Appears in Collections:Department of Infectious Diseases